Author:
Della Badia Laura A.,Elshourbagy Nabil A.,Mousa Shaker A.
Subject
Pharmacology (medical),Pharmacology
Reference108 articles.
1. Anti-pcsk9 compounds and methods for the treatment and/or prevention of cardiovascular diseases;Abdel-Meguid,2014
2. Anti-proprotein convertase subtilisin kexin type 9 (anti-pcsk9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases.;Abdel-Meguid,2014
3. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia;Abifadel;Nat Genet,2003
4. Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia;Ballantyne;Am J Cardiol,2015
5. Lipids, blood pressure and kidney update 2014;Banach;Pharmacol Res,2015
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献